Join
Live feed
·
INSIDERFilingvia Quantisnow
Cellular Biomedicine Group, Inc. logo

SEC Form 4: K Andrew Chan was granted 48,000 units of Common Stock and disposed to the issuer $0 worth of Common Stock (239,747 units at $0.00), decreasing ownership by 100% to 0 units

ByQuantisnow·Wall Street's wire, on your screen.
CBMG· Cellular Biomedicine Group, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CBMG (Cellular Biomedicine Group, Inc.) and more on Quantisnow.